-
1
-
-
0037434561
-
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
-
Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.N Engl J Med 2003;348:593-600.
-
(2003)
N Engl J Med
, vol.348
, pp. 593-600
-
-
Hill, J.M.1
Zalos, G.2
Halcox, J.P.3
Schenke, W.H.4
Waclawiw, M.A.5
Quyyumi, A.A.6
Finkel, T.7
-
2
-
-
0031019745
-
Isolation of putative progenitor endothelial cells for angiogenesis
-
Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichier B, Schatteman G, Isner I. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1999;275:964-967.
-
(1999)
Science
, vol.275
, pp. 964-967
-
-
Asahara, T.1
Murohara, T.2
Sullivan, A.3
Silver, M.4
van der Zee, R.5
Li, T.6
Witzenbichier, B.7
Schatteman, G.8
Isner, I.9
-
3
-
-
51649099800
-
Assessing identity, phenotype, and fate of endothelial progenitor cells
-
Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Artherioscler Thromb Vasc Biol 2008;28:1584-1595.
-
(2008)
Artherioscler Thromb Vasc Biol
, vol.28
, pp. 1584-1595
-
-
Hirschi, K.K.1
Ingram, D.A.2
Yoder, M.C.3
-
4
-
-
74049140758
-
Phenotypes of stem cells from diverse origin
-
Tàrnok A, Ulrich H, Bocsi J. Phenotypes of stem cells from diverse origin. Cytometry A 2010;77A:6-10.
-
(2010)
Cytometry A
, vol.77
, pp. 6-10
-
-
Tàrnok, A.1
Ulrich, H.2
Bocsi, J.3
-
5
-
-
33646433695
-
Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels
-
Zentilin L, Tafuro S, Zacchigna S, Arsic N, Pattarini L, Sinigaglia M, Giacca M. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 2006;107:3546-3554.
-
(2006)
Blood
, vol.107
, pp. 3546-3554
-
-
Zentilin, L.1
Tafuro, S.2
Zacchigna, S.3
Arsic, N.4
Pattarini, L.5
Sinigaglia, M.6
Giacca, M.7
-
6
-
-
27944479679
-
Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferetiation into endothelial cells
-
O'Neill TJ, Wamhoff BR, Owens GK, Skalak TC. Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferetiation into endothelial cells. Circ Res 2005;97:1027-1035.
-
(2005)
Circ Res
, vol.97
, pp. 1027-1035
-
-
O'Neill, T.J.1
Wamhoff, B.R.2
Owens, G.K.3
Skalak, T.C.4
-
7
-
-
0038692859
-
Endothelial progenitor cells: isolation and characterization
-
Hristov M, Erl W, Weber PC. Endothelial progenitor cells: isolation and characterization. Trends Cardiovasc Med 2003;13:201-206.
-
(2003)
Trends Cardiovasc Med
, vol.13
, pp. 201-206
-
-
Hristov, M.1
Erl, W.2
Weber, P.C.3
-
8
-
-
30644480576
-
Optimized flow cytometric analysis of endothelial progenitor cells in peripheral blood
-
Rustemeyer P, Wittkoski W, Jurk K, Koller A. Optimized flow cytometric analysis of endothelial progenitor cells in peripheral blood.J Immunoassay Immunochem 2006;27:77-88.
-
(2006)
J Immunoassay Immunochem
, vol.27
, pp. 77-88
-
-
Rustemeyer, P.1
Wittkoski, W.2
Jurk, K.3
Koller, A.4
-
9
-
-
0035160312
-
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
-
Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chaudburn A, Heissig B, Marks W, Witte L, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7:1194-1201.
-
(2001)
Nat Med
, vol.7
, pp. 1194-1201
-
-
Lyden, D.1
Hattori, K.2
Dias, S.3
Costa, C.4
Blaikie, P.5
Butros, L.6
Chaudburn, A.7
Heissig, B.8
Marks, W.9
Witte, L.10
-
10
-
-
20444458775
-
Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair
-
Schmidt-Luke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U, Dimmeler S, Zeiher AM. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981-2987.
-
(2005)
Circulation
, vol.111
, pp. 2981-2987
-
-
Schmidt-Luke, C.1
Rössig, L.2
Fichtlscherer, S.3
Vasa, M.4
Britten, M.5
Kämper, U.6
Dimmeler, S.7
Zeiher, A.M.8
-
11
-
-
33750240741
-
New flow cytometric technique for the evaluation of circulating endothelial progenitor cell levels in various disease groups
-
Dulic-Sills A, Blunden MJ, Mawdsley J, Bastin AJ, McAuley D, Griffiths M, Rampton DS, Yaqoob MM, Macey MG, Agrawal SG. New flow cytometric technique for the evaluation of circulating endothelial progenitor cell levels in various disease groups.J Immunol Methods 2006;316:107-115.
-
(2006)
J Immunol Methods
, vol.316
, pp. 107-115
-
-
Dulic-Sills, A.1
Blunden, M.J.2
Mawdsley, J.3
Bastin, A.J.4
McAuley, D.5
Griffiths, M.6
Rampton, D.S.7
Yaqoob, M.M.8
Macey, M.G.9
Agrawal, S.G.10
-
12
-
-
44349143198
-
Bone marrow-derived circulating endothelial precursor do not contribute to vascular endothelium and are not needed for tumor growth
-
Purhonen S, Palm J, Rossi D, Kaskenpaa N, Rajantie I, Yla-Herttuala S, Alitalo K, Weissman IL, Salven P. Bone marrow-derived circulating endothelial precursor do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci USA 2008;105:6620-6625.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 6620-6625
-
-
Purhonen, S.1
Palm, J.2
Rossi, D.3
Kaskenpaa, N.4
Rajantie, I.5
Yla-Herttuala, S.6
Alitalo, K.7
Weissman, I.L.8
Salven, P.9
-
13
-
-
33746503824
-
Circulating endothelial cells and endothelial progenitor cells: Two side of the same coin, or two different coins?
-
Blann AD, Pretorius A. Circulating endothelial cells and endothelial progenitor cells: Two side of the same coin, or two different coins? Atherosclerosis 2006;188:12-18.
-
(2006)
Atherosclerosis
, vol.188
, pp. 12-18
-
-
Blann, A.D.1
Pretorius, A.2
-
14
-
-
0038367708
-
Circulating endothelial cells as a novel marker of angiogenesis
-
Mancuso P, Calleri A, Cassi C, Gobbi A, Capillo M, Pruneri G, Martinelli G, Bertolini F. Circulating endothelial cells as a novel marker of angiogenesis. Adv Exp Med Biol 2003;522:83-97.
-
(2003)
Adv Exp Med Biol
, vol.522
, pp. 83-97
-
-
Mancuso, P.1
Calleri, A.2
Cassi, C.3
Gobbi, A.4
Capillo, M.5
Pruneri, G.6
Martinelli, G.7
Bertolini, F.8
-
15
-
-
1642315914
-
Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with he von Willebrand factor and tissue factor
-
Makin AJ, Blann AD, Chung NA, Silverman SH, Lip GY. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with he von Willebrand factor and tissue factor. Eur Heart J 2004;25:371-376.
-
(2004)
Eur Heart J
, vol.25
, pp. 371-376
-
-
Makin, A.J.1
Blann, A.D.2
Chung, N.A.3
Silverman, S.H.4
Lip, G.Y.5
-
17
-
-
0033667405
-
Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM-1 in blood
-
Kas-Deelen AM, Harmsen MC, De Maar EF, Oost-Kort WW, Tervaert JW, Van Der Meer J, Van Son WJ, The TH. Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM-1 in blood. Kidney Int 2000;58:2533-2542.
-
(2000)
Kidney Int
, vol.58
, pp. 2533-2542
-
-
Kas-Deelen, A.M.1
Harmsen, M.C.2
De Maar, E.F.3
Oost-Kort, W.W.4
Tervaert, J.W.5
Van Der Meer, J.6
Van Son, W.J.7
The, T.H.8
-
18
-
-
73749083481
-
Global estimates of the prevalence of diabetes for 2010 and 2030
-
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14.
-
(2010)
Diabetes Res Clin Pract
, vol.87
, pp. 4-14
-
-
Shaw, J.E.1
Sicree, R.A.2
Zimmet, P.Z.3
-
19
-
-
77649336781
-
Global healthcare expenditure on diabetes for 2010 and 2030
-
Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, Nichols G. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:293-301.
-
(2010)
Diabetes Res Clin Pract
, vol.87
, pp. 293-301
-
-
Zhang, P.1
Zhang, X.2
Brown, J.3
Vistisen, D.4
Sicree, R.5
Shaw, J.6
Nichols, G.7
-
20
-
-
0032960337
-
Effect of diabetes mellitus on formation of coronary collateral vessels
-
Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinç H, Ergin A. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999;99:2239-2242.
-
(1999)
Circulation
, vol.99
, pp. 2239-2242
-
-
Abaci, A.1
Oguzhan, A.2
Kahraman, S.3
Eryol, N.K.4
Unal, S.5
Arinç, H.6
Ergin, A.7
-
21
-
-
0037184495
-
Molecular understanding of hyperglycemia's adverse effects for diabetic complications
-
Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002;288:2579-2588.
-
(2002)
JAMA
, vol.288
, pp. 2579-2588
-
-
Sheetz, M.J.1
King, G.L.2
-
22
-
-
51349156152
-
Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing
-
Liu Z-J, Velasquez OC. Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal 2008;10:1869-1882.
-
(2008)
Antioxid Redox Signal
, vol.10
, pp. 1869-1882
-
-
Liu, Z.-J.1
Velasquez, O.C.2
-
23
-
-
27744446021
-
Ghrelin improves endothelial function in patients with metabolic syndrome
-
Tesauro M, Scinzari F, Iantorno M, Rizza S, Melina D, Lauro D, Cardillo C. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 2005;112:2986-2992.
-
(2005)
Circulation
, vol.112
, pp. 2986-2992
-
-
Tesauro, M.1
Scinzari, F.2
Iantorno, M.3
Rizza, S.4
Melina, D.5
Lauro, D.6
Cardillo, C.7
-
24
-
-
9444236184
-
Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus
-
Katsuki A, Urakawa H, Gabazza EC, Murashima S, Nakatani K, Togashi K, Yano Y, Adachi Y, Sumida Y. Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus. Eur J Endocrinol 2004;151:573-577.
-
(2004)
Eur J Endocrinol
, vol.151
, pp. 573-577
-
-
Katsuki, A.1
Urakawa, H.2
Gabazza, E.C.3
Murashima, S.4
Nakatani, K.5
Togashi, K.6
Yano, Y.7
Adachi, Y.8
Sumida, Y.9
-
25
-
-
77954749961
-
Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats
-
Granata R, Volante M, Settanni F, Gauna C, Ghé C, Annunziata M, Deidda B, Gesmundo I, Abribat T, van der Lely AJ, et al. Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats.J Mol Endocrinol 2010;45:9-17.
-
(2010)
J Mol Endocrinol
, vol.45
, pp. 9-17
-
-
Granata, R.1
Volante, M.2
Settanni, F.3
Gauna, C.4
Ghé, C.5
Annunziata, M.6
Deidda, B.7
Gesmundo, I.8
Abribat, T.9
van der Lely, A.J.10
-
26
-
-
77951156798
-
Unacylated ghrelin rescues endothelial progenitor cell function in individuals with type 2 diabetes
-
Togliatto G, Trombetta A, Dentelli P, Baragli A, Rosso A, Granata R, Ghigo D, Pegoraro L, Ghigo E, Brizzi MF. Unacylated ghrelin rescues endothelial progenitor cell function in individuals with type 2 diabetes. Diabetes 2010;59:1016-1025.
-
(2010)
Diabetes
, vol.59
, pp. 1016-1025
-
-
Togliatto, G.1
Trombetta, A.2
Dentelli, P.3
Baragli, A.4
Rosso, A.5
Granata, R.6
Ghigo, D.7
Pegoraro, L.8
Ghigo, E.9
Brizzi, M.F.10
-
27
-
-
35348979155
-
Relationship between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome
-
Barazzoni R, Zanetti M, Ferreira C, Vinci P, Pirulli A, Mucci MP, Dore F, Fonda M, Ciocchi B, Cattin L, et al. Relationship between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome.J Clin Endocrinol 2007;92:3935-3940.
-
(2007)
J Clin Endocrinol
, vol.92
, pp. 3935-3940
-
-
Barazzoni, R.1
Zanetti, M.2
Ferreira, C.3
Vinci, P.4
Pirulli, A.5
Mucci, M.P.6
Dore, F.7
Fonda, M.8
Ciocchi, B.9
Cattin, L.10
-
29
-
-
21844469734
-
Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry
-
Khan SS, Solomon MA, McCoy JP Jr. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B 2005;64B:1-8.
-
(2005)
Cytometry B
, vol.64
, pp. 1-8
-
-
Khan, S.S.1
Solomon, M.A.2
McCoy Jr., J.P.3
-
31
-
-
40649125770
-
Quantification of circulating endothelial progenitor cells: A methodological comparison of six flow cytometric approaches
-
Van Craenenbroek EMF, Conraads VMA, Van Bockstaele DR, Haine SE, Vermeulen K, Van Tendeloo VF, Vrints CJ, Hoymans VY. Quantification of circulating endothelial progenitor cells: A methodological comparison of six flow cytometric approaches.J Immunol Methods 2008;332:31-40.
-
(2008)
J Immunol Methods
, vol.332
, pp. 31-40
-
-
Van Craenenbroek, E.M.F.1
Conraads, V.M.A.2
Van Bockstaele, D.R.3
Haine, S.E.4
Vermeulen, K.5
Van Tendeloo, V.F.6
Vrints, C.J.7
Hoymans, V.Y.8
-
32
-
-
12944253116
-
Expression of VEGFR-2 and AC-133 by circulating humani CD34(+) identifies a population of functional endothelial precursors
-
Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, et al. Expression of VEGFR-2 and AC-133 by circulating humani CD34(+) identifies a population of functional endothelial precursors. Blood 2000;95:965-958.
-
(2000)
Blood
, vol.95
, pp. 965-958
-
-
Peichev, M.1
Naiyer, A.J.2
Pereira, D.3
Zhu, Z.4
Lane, W.J.5
Williams, M.6
Oz, M.C.7
Hicklin, D.J.8
Witte, L.9
Moore, M.A.10
-
34
-
-
68949154481
-
The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: Is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process?
-
Yoder MC, Ingram DA. The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: Is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process? Biochim Biophys Acta 2009;1796:50-54.
-
(2009)
Biochim Biophys Acta
, vol.1796
, pp. 50-54
-
-
Yoder, M.C.1
Ingram, D.A.2
-
35
-
-
40949152378
-
Technical notes on endothelial progenitor cells: Ways to escape from the knowledge plateau
-
Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A. Technical notes on endothelial progenitor cells: Ways to escape from the knowledge plateau. Atherosclerosis 2008;197:496-503.
-
(2008)
Atherosclerosis
, vol.197
, pp. 496-503
-
-
Fadini, G.P.1
Baesso, I.2
Albiero, M.3
Sartore, S.4
Agostini, C.5
Avogaro, A.6
-
36
-
-
17644433975
-
Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease
-
Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zehiler AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89: e1-e7.
-
(2001)
Circ Res
, vol.89
-
-
Vasa, M.1
Fichtlscherer, S.2
Aicher, A.3
Adler, K.4
Urbich, C.5
Martin, H.6
Zehiler, A.M.7
Dimmeler, S.8
-
37
-
-
9144271032
-
Endothelial progenitor cell dysfunction: A novel concept in the pathogenesis of vascular complications of type 1 diabetes
-
Loomans CJM, de Koning EJP, Staal FJT, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld AJ. Endothelial progenitor cell dysfunction: A novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004;53:195-199.
-
(2004)
Diabetes
, vol.53
, pp. 195-199
-
-
Loomans, C.J.M.1
de Koning, E.J.P.2
Staal, F.J.T.3
Rookmaaker, M.B.4
Verseyden, C.5
de Boer, H.C.6
Verhaar, M.C.7
Braam, B.8
Rabelink, T.J.9
van Zonneveld, A.J.10
-
38
-
-
0037180517
-
Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures
-
Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jocobowitz GR, Levine JP, Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002;106:2781-2786.
-
(2002)
Circulation
, vol.106
, pp. 2781-2786
-
-
Tepper, O.M.1
Galiano, R.D.2
Capla, J.M.3
Kalka, C.4
Gagne, P.J.5
Jocobowitz, G.R.6
Levine, J.P.7
Gurtner, G.C.8
-
39
-
-
61849161661
-
Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2
-
Cheng Q, Dong L, Wang L, Kang L, Xu B. Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2. Biochem Biophys Res Commun 2009;381:192-197.
-
(2009)
Biochem Biophys Res Commun
, vol.381
, pp. 192-197
-
-
Cheng, Q.1
Dong, L.2
Wang, L.3
Kang, L.4
Xu, B.5
-
40
-
-
60049084417
-
Complications impaired endothelial progenitor cell function in type 2 diabetic patients with or without critical leg ischaemia: Implication for impaired neovascularization in diabetes
-
Chen MC, Sheu JJ, Wang PW, Chen CY, Kuo MC, Hsieh CJ, Chen JF, Chang HW. Complications impaired endothelial progenitor cell function in type 2 diabetic patients with or without critical leg ischaemia: Implication for impaired neovascularization in diabetes. Diab Med 2009;26:134-141.
-
(2009)
Diab Med
, vol.26
, pp. 134-141
-
-
Chen, M.C.1
Sheu, J.J.2
Wang, P.W.3
Chen, C.Y.4
Kuo, M.C.5
Hsieh, C.J.6
Chen, J.F.7
Chang, H.W.8
-
41
-
-
77956617549
-
Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes
-
Jung C, Rafnsson A, Shemyakin A, Böhm F, Pernow J. Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes. Int J Cardiol 2010;143:368-372.
-
(2010)
Int J Cardiol
, vol.143
, pp. 368-372
-
-
Jung, C.1
Rafnsson, A.2
Shemyakin, A.3
Böhm, F.4
Pernow, J.5
-
42
-
-
1542379710
-
Impairment in ischemic-induced neovascularization in diabetes: Bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment
-
Tamarat R, Silvestre JS, Le Ricousse-Roussanne S, Barateau V, Leconte-Raclet L, Clergue M, Duriez M, Tobelem G, Levi BI. Impairment in ischemic-induced neovascularization in diabetes: Bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am J Phatol 2004;164: 457-466.
-
(2004)
Am J Phatol
, vol.164
, pp. 457-466
-
-
Tamarat, R.1
Silvestre, J.S.2
Le Ricousse-Roussanne, S.3
Barateau, V.4
Leconte-Raclet, L.5
Clergue, M.6
Duriez, M.7
Tobelem, G.8
Levi, B.I.9
-
43
-
-
3142729178
-
Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines
-
Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004;110:227-239.
-
(2004)
Circulation
, vol.110
, pp. 227-239
-
-
Grundy, S.M.1
Cleeman, J.I.2
Merz, C.N.3
Brewer Jr., H.B.4
Clark, L.T.5
Hunninghake, D.B.6
Pasternak, R.C.7
Smith Jr., S.C.8
Stone, N.J.9
-
44
-
-
0141643291
-
Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes
-
Pöykkö SM, Kellokoski E, Hörkkö S, Kauma H, Kesäniemi YA, Ukkoia O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003;52:2546-2553.
-
(2003)
Diabetes
, vol.52
, pp. 2546-2553
-
-
Pöykkö, S.M.1
Kellokoski, E.2
Hörkkö, S.3
Kauma, H.4
Kesäniemi, Y.A.5
Ukkoia, O.6
|